Vida Ventures Advisors, LLC Allogene Therapeutics, Inc. Transaction History
Vida Ventures Advisors, LLC
- $5.05 Million
- Q1 2025
A detailed history of Vida Ventures Advisors, LLC transactions in Allogene Therapeutics, Inc. stock. As of the latest transaction made, Vida Ventures Advisors, LLC holds 1,798,163 shares of ALLO stock, worth $2.61 Million. This represents 55.14% of its overall portfolio holdings.
Number of Shares
1,798,163
Previous 1,798,163
-0.0%
Holding current value
$2.61 Million
Previous $3.83 Million
27.23%
% of portfolio
55.14%
Previous 4.68%
Shares
1 transactions
Others Institutions Holding ALLO
# of Institutions
178Shares Held
139MCall Options Held
75.8KPut Options Held
52.8K-
Tpg Gp A, LLC Fort Worth, TX18.7MShares$27.1 Million1.1% of portfolio
-
Black Rock Inc. New York, NY16.4MShares$23.8 Million0.0% of portfolio
-
Lynx1 Capital Management LP San Juan, PR10.9MShares$15.8 Million9.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8MShares$11.6 Million0.0% of portfolio
-
State Street Corp Boston, MA7.25MShares$10.5 Million0.0% of portfolio
About Allogene Therapeutics, Inc.
- Ticker ALLO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 143,807,008
- Market Cap $209M
- Description
- Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult p...